#Growth « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘#Growth’

Empower Clinics Emerges: Unveiling Significant Growth and a Visionary Strategy to Reinvigorate Investor Confidence

Posted by Paul Nanuwa at 3:12 PM on Thursday, April 11th, 2024

As the clinical trials market propels towards an estimated value of USD 887.0 Billion by 2032, Empower Clinics stands at the forefront of harnessing these burgeoning opportunities. Amidst the industry’s dynamic landscape, Empower Clinics is strategically positioned to leverage its expertise and drive innovation in medical research and patient-centric initiatives.

Industry Outlook and Empower Clinics’ Trajectory

The clinical trials industry is witnessing unprecedented growth fueled by escalating demand for innovative therapies and treatments. Empower Clinics is poised to navigate this trajectory with precision, capitalizing on emerging trends and technological advancements to drive transformative change. As the industry evolves, Empower Clinics remains steadfast in its commitment to advancing medical research and delivering impactful solutions.

Voices of Authority

Industry leaders echo Empower Clinics’ strategic vision, recognizing the company’s pivotal role in shaping the future of clinical trials. With a focus on collaboration and innovation, Empower Clinics is poised to drive meaningful advancements that enhance patient outcomes and revolutionize healthcare delivery.

Empower Clinics’ FLASH Highlights

Empower Clinics is a healthcare company with a growing research and clinical trials division that is currently achieving early success in the Dallas and Los Angeles markets. It has already been awarded its first clinical trial from a Global Fortune 500 Pharmaceutical Company and the company has grown their active sites from 2 in the fall to 6 at present. Principal Investigators have increased from 6 to 14 with an active pipeline in motion. That foundation of doctors and medical offices opens the door to potential major contract wins from pharmaceutical companies that need speed and smarts from partners like Empower to get their clinical trials completed.

Real-world Relevance

Empower Clinics’ impact extends beyond the laboratory, translating into tangible benefits for patients and stakeholders alike. By championing patient-centric approaches and leveraging advanced technologies, Empower Clinics is at the forefront of delivering transformative healthcare solutions that address pressing medical challenges.

Looking Ahead with Empower Clinics

As the clinical trials industry continues to evolve, Empower Clinics remains focused on its mission to drive innovation and improve patient outcomes. With a forward-thinking approach and a dedication to excellence, Empower Clinics is poised to unlock new opportunities and redefine the future of medical research and patient care.

Conclusion

In a landscape defined by unprecedented growth and innovation, Empower Clinics emerges as a leader in the clinical trials arena. As the industry continues to evolve, Empower Clinics stands ready to lead the charge towards a brighter, more innovative future.

YOUR NEXT STEPS

Visit $EPW HUB On AGORACOM: https://agoracom.com/ir/EmpowerClinics
Visit $EPW 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/EmpowerClinics/profile
Visit $EPW Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/EmpowerClinics/forums/discussion

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor. Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visit https://agoracom.com/terms-and-conditions

Tags: #Growth, #Market, #Trials, article, clinical, clinics, Healthcare, leader, Pennystocks, pharma, pharmaceuticals, smallcap, smallcaps, SmallCapStocks, stocks
Posted in AGORACOM Client Feature, AGORACOM Sector Spotlight, AGORACOM Small Cap Stocks For Investment, AGORACOM Traffic, All Recent Posts, Empower Clinics Inc. | Comments Off on Empower Clinics Emerges: Unveiling Significant Growth and a Visionary Strategy to Reinvigorate Investor Confidence

Vertical Exploration $VERT.ca Ships Additional Wollastonite from St-Onge to BC Bud Depot Cannabis Facilities

Posted by AGORACOM at 8:20 AM on Monday, May 6th, 2019

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564648/hub/vertical.png

Shipped an additional 100 Kilograms of Wollastonite from its St-Onge deposit for use at BC Bud Depot ACMPR-licenced Research and Development facilities
The wollastonite will be used as a natural soil additive to enhance overall cannabis plant health and improve cultivation and production
Adding wollastonite at an admixture rate of 10-15% to the growth medium will result in significant improvements in root mass, powdery mildew control and pest elimination

VANCOUVER, BC / ACCESSWIRE / May 6, 2019 / VERTICAL EXPLORATION INC. (TSX-V: VERT) (“Vertical” or the “Company”) is pleased to announce that it has shipped an additional 100 Kilograms of wollastonite from its St-Onge deposit for use at BC Bud Depot’s (BCBD) ACMPR-licenced Research and Development facilities in Vancouver, BC. The wollastonite will be used as a natural soil additive to enhance overall cannabis plant health and improve cultivation and production at BCBD’s facilities.

Peter P. Swistak, president and chief executive officer of Vertical Exploration, commented: “We are very happy to provide this additional shipment of wollastonite to BCBD for use at their Vancouver cannabis facilities, as it further validates the success of the Phase Three cannabis research trials that took place earlier this year at BCBD’s facilities which were announced by the Company on February 5th, 2019. This shipment is also further confirmation of Vertical’s efforts to aggressively move forward with additional test marketing of our high-quality St. Onge wollastonite with a range of cannabis industry companies and producers.”

“We are thrilled to be able to receive an additional shipment of Vertical’s wollastonite to support cannabis cultivation at our ACMPR-licenced Research and Development facilities,” stated Matthew Harvey, CEO of BCBD. “After being part of the very encouraging Phase Three cannabis trials, I am convinced that adding wollastonite at an admixture rate of 10-15% to the growth medium will result in significant improvements in root mass, powdery mildew control and pest elimination. I firmly believe that wollastonite, with all of its highly beneficial plant health properties, will be increasingly seen by the cannabis industry as the natural mineral supplement answer because it couples crop protection with product improvement which ultimately means a more natural and healthier product for consumers.”

Vertical anticipates providing further updates on its cannabis testing and marketing efforts in the coming months.

ABOUT VERTICAL EXPLORATION

Vertical Exploration’s mission is to identify, acquire, and advance high potential mining prospects located in North America for the benefit of its stakeholders. The Company’s flagship St-Onge Wollastonite property is located in the Lac-Saint-Jean area in the Province of Quebec.

ON BEHALF OF THE BOARD

Peter P. Swistak, President and CEO

Telephone: 1-604-683-3995
Toll Free: 1-888-945-4770

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: #BC, #Growth, #Soil, #VERT, #Vertical, #Wollastonite, Marijuana
Posted in All Recent Posts, Vertical Exploration Inc | Comments Off on Vertical Exploration $VERT.ca Ships Additional Wollastonite from St-Onge to BC Bud Depot Cannabis Facilities

CLIENT FEATURE: $VERT.ca Vertical Exploration – Developing the St. Onge Wollastonite Project $TORR.ca $FA.ca

Posted by AGORACOM at 12:29 PM on Friday, April 26th, 2019

St-Onge-Wollastonite Deposit located approximately 90 kilometres Northwest of the city of Saguenay, in St-Onge township, in the Saguenay-Lac-St-Jean region of Quebec, Canada.
Wollastonite is a calcium inosilicate mineral that may contain small amounts of iron, magnesium, and manganese substituting for calcium
Wollastonite is used primarily in ceramics, friction products (brakes and clutches), metalmaking, paint filler, and plastics.
Located close to Saguenay Port and year round shipping access

St-Onge-Wollastonite Deposit: Resource Classification

This image has an empty alt attribute; its file name is image-1-600x96.png

Utilizing Wollastonite as A Soil Additive

Vertical is researching the use of Wollastonite as a soil additive for optimizing marijuana growth
Phase Three trials involving cannabis grown with wollastonite (CaSiO3) as a soil additive at BC Bud Depot’s (BCBD) ACMPR-licenced Research and Development facilities in Vancouver, BC
Phase Three trials measured and recorded significant improvements in root mass, powdery mildew control and pest elimination.
In every case the most optimal results occurred with an admixture rate of 10% to 15% wollastonite to the growth medium

Hub on Agoracom

FULL DISCLOSURE: Vertical Exploration is an advertising client of AGORA Internet Relations Corp.

Tags: #Additive, #Agriculture, #Growth, #Quebec, #Trials, #VERT, #White, #Wollastonite, Cannabis
Posted in Vertical Exploration Inc | Comments Off on CLIENT FEATURE: $VERT.ca Vertical Exploration – Developing the St. Onge Wollastonite Project $TORR.ca $FA.ca

CLIENT FEATURE: $VERT.ca Vertical Exploration – Developing the St. Onge Wollastonite Project $TORR.ca $FA.ca

Posted by AGORACOM at 1:00 PM on Friday, April 12th, 2019

St-Onge-Wollastonite Deposit located approximately 90 kilometres Northwest of the city of Saguenay, in St-Onge township, in the Saguenay-Lac-St-Jean region of Quebec, Canada.
Wollastonite is a calcium inosilicate mineral that may contain small amounts of iron, magnesium, and manganese substituting for calcium
Wollastonite is used primarily in ceramics, friction products (brakes and clutches), metalmaking, paint filler, and plastics.
Located close to Saguenay Port and year round shipping access

St-Onge-Wollastonite Deposit: Resource Classification

Utilizing Wollastonite as A Soil Additive

Vertical is researching the use of Wollastonite as a soil additive for optimizing marijuana growth
Phase Three trials involving cannabis grown with wollastonite (CaSiO3) as a soil additive at BC Bud Depot’s (BCBD) ACMPR-licenced Research and Development facilities in Vancouver, BC
Phase Three trials measured and recorded significant improvements in root mass, powdery mildew control and pest elimination.
In every case the most optimal results occurred with an admixture rate of 10% to 15% wollastonite to the growth medium

Hub on Agoracom

FULL DISCLOSURE: Vertical Exploration is an advertising client of AGORA Internet Relations Corp.

$VERT Vertical Exploration Completes Successful Drilling Program at St. Onge Wollastonite Deposit $TORR $FA.ca

Posted by AGORACOM at 8:46 AM on Monday, March 18th, 2019

Twenty-three (23) drill holes totaling 1,784.0 metres were completed in less than two weeks of drilling (see Figure 1 & Table 1).
Twenty (20) drill holes intersected high-grade wollastonite zones, confirming excellent continuity and correlation with the thickly mineralized zones intersected by previously reported historical drill holes.
Sixteen (16) drill holes intersected high-grade wollastonite zones right up until the end of the hole, which are all open at depth.
A total of 1,107.5 meters of high-grade wollastonite mineralized core length was intersected, representing approximately 62% of all drilled core length.

VANCOUVER, BC / ACCESSWIRE / March 18, 2019 / VERTICAL EXPLORATION INC. (TSX-V: VERT) (“Vertical” or “the Company”) is pleased to announce that it has completed a successful diamond drilling and sampling program on its advanced stage St-Onge-Wollastonite Deposit located approximately 90 kilometres Northwest of the city of Saguenay, in St-Onge township, in the Saguenay-Lac-St-Jean region of Quebec, Canada.

The primary goal of the 2019 drilling program, which consisted of seven (7) drilling sections (see Figure 1, Sections A-G), was to establish an additional measured mineral resource of approximately 5 million tonnes of crude wollastonite. The pit constrained mineral resources at the St-Onge Wollastonite deposit, as previously reported in the Company’s August 2, 2018 news release, comprises an NI 43-101 compliant resources totaling 14 million tonnes at 36.61% Wollastonite in the measured and indicated class using a cut-off grade of 30% Wollastonite (7.1 million tonnes at 36.20% in measured and 6.9 million tonnes at 37.04% in indicated), and 17.9 million tonnes at 40.25% in the inferred class (rounded numbers). The NI 43-101 Technical Report was prepared by GoldMinds Geoservices Inc. (â€˜GMG’).

HIGHLIGHTS OF THE 2019 DRILLING CAMPAIGN

Twenty-three (23) drill holes totaling 1,784.0 metres were completed in less than two weeks of drilling (see Figure 1 & Table 1).
Twenty (20) drill holes intersected high-grade wollastonite zones, confirming excellent continuity and correlation with the thickly mineralized zones intersected by previously reported historical drill holes.
Sixteen (16) drill holes intersected high-grade wollastonite zones right up until the end of the hole, which are all open at depth.
A total of 1,107.5 meters of high-grade wollastonite mineralized core length was intersected, representing approximately 62% of all drilled core length.

In total, nine hundred thirteen (913) drill core samples of approximately 1.5 metres in length, including samples ranging from less than one 1.0 metre in length and up to a maximum of 2.5 metres in length, were collected for laboratory assaying. Eighty-one (81) of the 913 drill core samples were quality assurance/quality control (QA/QC) samples, including mineralized certified samples, blank samples and duplicate samples.

Peter P. Swistak, President and CEO of Vertical Exploration, commented: ”I am very pleased with the speed of completion and overall success of this 2019 drilling program. The mineral data obtained from the program will now allow the Company to further update its NI 43-101 Technical Report and continue to aggressively move forward with its plans to begin the quarry permitting process on its St-Onge-Wollastonite Deposit.”

Complete drilling results for the 23 hole program will be announced when received.

The diamond drilling program has been supervised by Jean-Paul Barrette P. Geo., a qualified person under National Instrument 43-101 contracted by Magnor Exploration Inc., and responsible for reviewing and approving the technical contents of this press release as they pertain to the St-Onge-Wollastonite property.

ABOUT VERTICAL EXPLORATION

Vertical Exploration’s mission is to identify, acquire, and advance high potential mining prospects located in North America for the benefit of its stakeholders. The Company’s flagship St-Onge-Wollastonite property is located in the Lac-Saint-Jean area in the Province of Quebec.

ON BEHALF OF THE BOARD

Peter P. Swistak, President

FOR FURTHER INFORMATION PLEASE CONTACT:

Telephone: 1-604-683-3995
Toll Free: 1-888-945-4770

Table 1: List of 2019 drill holes and wollastonite skarn intervals intersected

Figure 1: Location of historical and 2019 drill hole collars

SOURCE: Vertical Exploration Inc.

Tags: #Agriculture, #Drilling, #Growth, #Quebec, #VERT, #Wollastonite, Cannabis
Posted in Vertical Exploration Inc | Comments Off on $VERT Vertical Exploration Completes Successful Drilling Program at St. Onge Wollastonite Deposit $TORR $FA.ca

CLIENT FEATURE: AppliedBioSciences Investment In JUUL Labs Pays Dividend $WMD.ca $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM at 1:20 PM on Tuesday, March 5th, 2019

OTCQB: APPB

Received a capital distribution of $186,000 from its investment in JUUL Labs, Inc. (JUUL).

Altria Group Inc. (NYSE: MO) invested $12.8bn (35%), valuing JUUL at $38 billion.

JUUL is one of the fastest growing companies in the US, growing revenue to over $1 billion in a few short years.

The global e-cig and vaporizer market is one of the fastest growing consumer markets

Recently valued at $9.0 billion and
Expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024,

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology. The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com.

Contact
Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp.

Tags: #APPB, #Growth, #JUUL, CBD
Posted in Applied BioSciences | Comments Off on CLIENT FEATURE: AppliedBioSciences Investment In JUUL Labs Pays Dividend $WMD.ca $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Applied Biosciences $APPB Receives Distribution from Investment in JUUL Labs $HTIM $WMD $JUUL

Posted by AGORACOM at 11:28 AM on Tuesday, February 5th, 2019

Received a capital distribution of approximately $186,000 from its investment in JUUL Labs
Altria Group Inc. (NYSE: MO) invested $12.8bn in vaping company Juul Labs, a (35% stake) valuing JUUL at $38 billion
The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024
APPB has a market cap of $15m US & 10m S/O

LOS ANGELES, Feb. 05, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that has received a capital distribution of approximately $186,000 from its investment in JUUL Labs, Inc. (JUUL). The company has made strategic investments in select companies they believed to be innovators in the consumer space. The investment remains on the balance sheet under Equity Investments, but the company has begun a strategic review of options for the remaining equity stake.

Altria Group Inc. (NYSE: MO) on December 20, 2018 announced it had invested $12.8bn in vaping company Juul Labs, a 35% stake valuing JUUL at $38 billion. Howard Willard, Altriaâ€™s CEO said in a statement that the move was an effort to â€œprepare for a future where adult smokers overwhelmingly choose non-combustible products over cigarettes.â€

JUUL has become a success story and one of the fastest growing companies in the US, growing revenue to over $1 billion in a few short years. Their brand has become synonymous with vaping and the e-cigarette market.

The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024, according to Research Nestor (www.researchnester.com).

The company continues to make select investments in companies that can help shape the product roadmap and development of new products and potential partnerships.

Contact
Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Tags: #AltriaGroup, #APPB, #Consumer, #Growth, #HTIM, #JUUL, #TraceAnalytics, #WMD, Cannabis, Vape
Posted in Applied BioSciences | Comments Off on Applied Biosciences $APPB Receives Distribution from Investment in JUUL Labs $HTIM $WMD $JUUL

Vertical Exploration $VERT.ca Announces Wollastonite Research and Development Results

Posted by AGORACOM at 9:00 AM on Tuesday, February 5th, 2019

Successful completion of Phase Three trials involving cannabis grown with wollastonite (CaSiO3) as a soil additive
Phase Three trials BCBD measured and recorded significant improvements in root mass, powdery mildew control and pest elimination.
Optimal results occurred with an admixture rate of 10% to 15% Wollastonite to the growth medium

VANCOUVER, BC / February 5, 2019 / VERTICAL EXPLORATION INC. (TSX-V: VERT) (“Vertical” or the Company”) is pleased to announce the successful completion of Phase Three trials involving cannabis grown with wollastonite (CaSiO3) as a soil additive at BC Bud Depot’s (BCBD) ACMPR-licenced Research and Development facilities in Vancouver, BC. The positive Phase Three trials build on the success of Phase Two Trials, which included samples of marijuana grown with 15% wollastonite from the Company’s St. Onge project being entered in an international growers’ competition, winning first place overall for Best Flower at the August 2018 Kootenay Cannabis Cup in Cranbrook, BC. (see October 2, 2018 news release.)

In the Phase Three trials BCBD measured and recorded significant improvements in root mass, powdery mildew control and pest elimination. In every case the most optimal results occurred with an admixture rate of 10% to 15% wollastonite to the growth medium. Most notably, powdery mildew, the most common fungal blight to affect Cannabis sativa, was virtually undetectable with wollastonite admixture above 10%. An admixture above 10% wollastonite also correlated with sharp reductions in the presence of thrips and fungus gnats, insect pests with a sub-soil life phase in which the wollastonite crystals lacerate and impale their soft bodies. At a microscopic level, wollastonite’s needle-like structure penetrates soft-bodied insect larvae and pupae, interrupting the life cycle without the use of pesticides. Wollastonite’s unique properties also allow it to break down into calcium, magnesium and silicon in a highly bio-available form that balances soil PH throughout the growth cycle – this allows the cannabis plants to uptake silicic acid and promotes strong cell walls that better resist insect feeding and spore penetration, supporting increased growth and elevated product yields.

“We recorded a dramatic elevation of overall health among plants grown with wollastonite,” stated Matthew Harvey, CEO of BCBD. “The wollastonite group produced consistently low levels of powdery mildew — little to none – appearing later in the growth cycle. Roots, meanwhile, showed extreme vigour, growing dense and white with no sign of yellowing. Root health indicates a plant’s ability to resist disease and to support high yields of high-quality of finished marijuana.

According to Mr. Harvey the findings of the Phase Three BCBD wollastonite study indicate a major financial implication for the cannabis industry, where a trend towards cultivation of expansive plant canopies creates a powerful incentive for effective and efficient methods of crop protection and production.

As Mr. Harvey explained, “Large-scale cultivators need every tool at their disposal to improve plant health and avoid crop losses – a 10% to 20% loss in crop production due to a preventable outbreak of a destructive fungal pathogen can equate to millions of dollars of lost product. Companies that take crop protection seriously are looking for cost-effective soil additives that not only nourish plants but build resilience against the pests and pathogens that threaten profits. Our findings show wollastonite to be a critical tool for both cannabis crop protection and top-end production in a market where quality is of vital importance. It is no longer acceptable to spray fungicides on marijuana: natural prevention is the key and wollastonite is the answer.

Vertical’s CEO Peter Swistak commented: “We are very excited by these excellent Phase Three results which prove that wollastonite is a very appealing natural growing additive for the cannabis industry because it couples crop protection with product improvement, resulting in a more natural and healthier product for consumers.”

With the highly successful completion of these Phase Three cannabis trials at BCBD, Vertical is now moving aggressively forward with its plans to test market its high-quality St. Onge wollastonite to both micro-producers and large-scale cannabis companies. Vertical believes that the cannabis industry offers significant revenue potential for the company and anticipates providing further updates on its cannabis testing and marketing efforts in the near future.

ABOUT VERTICAL EXPLORATION

ON BEHALF OF THE BOARD
Peter P. Swistak, President

FOR FURTHER INFORMATION PLEASE CONTACT:

Telephone: 1-604-683-3995
Toll Free: 1-888-945-4770

FORWARD LOOKING STATEMENTS: This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in Canada (available at www.sedar.com).

SOURCE: Vertical Exploration Inc.

Tags: #Growth, #KootenayCannabisCup, #Trials, #Vertical, #Wollastonite, Cannabis
Posted in Vertical Exploration Inc | Comments Off on Vertical Exploration $VERT.ca Announces Wollastonite Research and Development Results

Posts Tagged ‘#Growth’

Categories